Health - Google News: The Return Of Vorapaxar, This Time For Post-MI Patients

Monday, August 27, 2012

Health - Google News

Google News

Aug 27th 2012, 08:03

The Return Of Vorapaxar, This Time For Post-MI Patients
Forbes
The once highly-promising novel antiplatelet agent vorapaxar, widely thought to be dead on arrival after unacceptably high serious bleeding rates were found in two large clinical trials, has now returned to active duty. On Sunday the drug's sponsor, ...
Data Mining May Revive VorapaxarMedPage Today
Merck to pursue approval for vorapaxar in prior MI patientsTheHeart.Org
Age, Weight May Define Benefits, Risks of Vorapaxar After MIFamily Practice News Digital Network
EurekAlert (press release) -TCTMD
all 6 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in:

Paparazziii